Selincro is a medication developed by Lundbeck to treat alcohol dependence by reducing the pleasurable effects of drinking alcohol and decreasing the urge to drink. It was approved by the European Medicines Agency in 2013 based on evidence it effectively reduced alcohol consumption in heavy drinkers without major safety concerns. Selincro works by reducing the euphoria experienced from drinking alcohol but does not prevent intoxication.

1. Medical Advances
Monica García
Kelly Lemus

2. • Selincro also known as Nalmefene is a
treatment for alcohol dependence in
patients who have a high drinking risk
level (DRL).

3. Selincro
Selincro is a way of curing alcoholism
invented by a Danish pharmaceutical
company named Lundbeck.

4. This medicine consists in pills that
reduce the euphoria sensation that
the patient feels when he or she drinks
alcohol, reducing the desire of drinking
it. Selincro is also effective to avoid
opioid’s addiction.

5. Selincro was approved by the
European Medicines Agency and
started to be sold at European
pharmacies in 2013.

6. Why has Selincro been approved?
. The CHMP noted that Selincro was shown
to be effective in reducing alcohol
consumption in men
drinking more than 60 g and women
drinking more than 40 g a day. With regard
to safety, the side
effects reported in the studies did not raise
any major concerns.

7. How does it works?
Helps to reduce the urge to drink in people
accustomed to large amounts of alcohol.
Selincro does not prevent the intoxicating
effects of alcohol.